Homogeneous plate based antibody internalization assay using pH sensor fluorescent dye

Nidhi Nath1, Becky Godat1, Chad Zimprich1

  • 1Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711, United States.

Insights

A novel pH-sensitive dye enables real-time measurement of antibody internalization into cancer cells, improving drug delivery and pharmacokinetic profiling for antibody therapeutics.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Receptor-mediated antibody internalization is crucial for anti-cancer antibody therapeutics like antibody-drug conjugates (ADCs).
  • Current methods for studying antibody internalization are often multistep, low-throughput, and provide only endpoint data.
  • Efficient internalization impacts drug delivery, receptor modulation, and pharmacokinetics, influencing therapeutic efficacy.

Purpose of the Study:

  • To develop a new homogeneous, time- and concentration-dependent method for measuring antibody internalization.
  • To utilize a novel hydrophilic and bright pH sensor dye (pHAb dye) for this purpose.
  • To demonstrate the utility of the pHAb dye for studying receptor-mediated antibody internalization and for early-stage monoclonal antibody development.

Main Methods:

  • Antibodies targeting cell surface receptors were conjugated with the pHAb dye, which is non-fluorescent at neutral pH and fluorescent at acidic pH.
  • Cells expressing target receptors were incubated with the labeled antibodies.
  • Internalization was measured by detecting the fluorescence signal generated as the dye enters acidic intracellular compartments (endosomes/lysosomes).
  • Labeling strategies (amine and thiol chemistries) and dye-to-antibody ratios were investigated using Trastuzumab (anti-HER2) and Cetuximab (anti-EGFR).

Main Results:

  • The pHAb dye enables homogeneous, time- and concentration-dependent measurements of antibody internalization.
  • The hydrophilic nature of the dye minimizes antibody aggregation.
  • The method demonstrated successful labeling and internalization studies with therapeutic antibodies Trastuzumab and Cetuximab.
  • Two novel approaches for high-throughput screening during early monoclonal antibody development were presented.

Conclusions:

  • The pHAb dye provides a sensitive and efficient tool for studying receptor-mediated antibody internalization.
  • This homogeneous assay format offers advantages over traditional methods, including higher throughput and real-time monitoring.
  • The developed method and approaches are valuable for optimizing antibody-based cancer therapeutics and accelerating early-stage drug development.

Related Concept Videos